|
Anyone have an opinion on this one. I believe they are involved in the medical database and software solutions business. I think it is a good buy. They have stumbled all the way down from about $25 a share to about $4 a share. The book value of the stock is about $50 million which includes about a $25 million cash balance. Compare this with their current market cap of only about $30 million!! Their last quarter was profitable. It appears their troubles for the most part have subsided. I think MDMD could easily gain a point or two in the short term. Any comments!!!! |